Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Burkitt Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Meningeal Carcinomatosis 7Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Acute 5Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Glioblastoma 3Astrocytoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Meningeal Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Lymphoma 2Glioma 2Brain Neoplasms 2Vomiting 1Uveal Melanoma 1Rhabdomyosarcoma 1Psychomotor Agitation 1Pain, Postoperative 1Oligodendroglioma 1Nevus 1Neoplasm Recurrence, Local 1Multiple Myeloma 1

Interventions

Ipilimumab 29Nivolumab 23pembrolizumab 14incomplete Freund's adjuvant 10Cyclophosphamide 10Interleukin-2 9Melphalan 8CTLA-4 Antigen 8sargramostim 7Temozolomide 7MART-1 Antigen 7Dacarbazine 7tebentafusp 6Ranibizumab 6montanide ISA 51 5fludarabine phosphate 5fludarabine 5Sunitinib 5Radiosurgery 5Carboplatin 5Bevacizumab 5aldesleukin 4aflibercept 4Magnetic Resonance Spectroscopy 4Granulocyte-Macrophage Colony-Stimulating Factor 4Blood Specimen Collection 4Biopsy 4trametinib 3sotrastaurin 3relatlimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uveal Melanoma × Spinal Puncture × Clear all
NCT03025256 2026-05-05

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Recruiting
75 enrolled
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡